| 摘要 |
FIELD: biotechnology, medicine. ^ SUBSTANCE: Zalpha 11-ligand is isolated from cDNA library generated from activated cells of human peripheral blood that have been selected from CD3. Animal is inoculated with Zalpha 11-ligand and antibodies are prepared that are able to bind specifically with epitopes, peptides or polypeptides of Zalpha 11-ligand. Invention provides effective regulation and/or development of hemopoietic cells in vitro and in vivo. Invention can be used for preparing Zalpha 11-ligand and antibodies for it. ^ EFFECT: valuable properties of new cytokine. ^ 18 cl, 5 tbl, 1 dwg, 55 ex |
